ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 172 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,756,000 | -44.3% | 543,063 | -38.7% | 0.46% | -42.9% |
| Q3 2016 | $12,137,000 | -20.0% | 886,561 | -56.8% | 0.80% | -26.1% |
| Q2 2016 | $15,168,000 | +35.5% | 2,052,525 | +17.2% | 1.08% | +30.6% |
| Q1 2016 | $11,194,000 | +12.5% | 1,751,813 | +10.0% | 0.83% | +16.8% |
| Q4 2015 | $9,953,000 | +26.4% | 1,592,527 | +18.1% | 0.71% | +11.5% |
| Q3 2015 | $7,873,000 | -23.7% | 1,348,195 | +8.0% | 0.64% | -31.3% |
| Q2 2015 | $10,320,000 | +21.8% | 1,247,917 | +21.4% | 0.93% | +5.1% |
| Q1 2015 | $8,473,000 | +7.0% | 1,028,263 | -10.8% | 0.88% | -13.5% |
| Q4 2014 | $7,917,000 | +122.4% | 1,152,466 | +74.8% | 1.02% | +9.6% |
| Q3 2014 | $3,560,000 | -11.0% | 659,232 | +5.0% | 0.93% | -14.6% |
| Q2 2014 | $4,000,000 | +70.6% | 627,968 | +115.9% | 1.09% | +7.7% |
| Q1 2014 | $2,345,000 | +79.1% | 290,886 | +51.5% | 1.01% | +7.2% |
| Q4 2013 | $1,309,000 | – | 191,965 | – | 0.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $82,111,000 | 18.09% |
| Consonance Capital Management LP | 5,575,742 | $35,629,000 | 5.39% |
| Opaleye Management Inc. | 1,250,000 | $7,988,000 | 4.98% |
| Tamarack Advisers, LP | 1,600,000 | $10,224,000 | 3.58% |
| Camber Capital Management LP | 5,405,235 | $34,539,000 | 2.02% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 324,636 | $2,074,000 | 1.36% |
| Palo Alto Investors LP | 2,248,317 | $14,367,000 | 1.12% |
| 1492 Capital Management LLC | 202,500 | $1,294,000 | 1.09% |
| Geduld E E | 120,100 | $767,000 | 1.05% |
| JS Capital Management LLC | 868,700 | $5,551,000 | 1.00% |